Gedeborg R, Garmo H, Thellenberg-Karlsson C, Fallara G, Styrke J, Franck Lissbrant I, et al. Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study. AO [Internet]. 2022 Mar. 4 [cited 2024 Nov. 24];61(3):328-32. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/21442